Form 4: Analog Devices CEO Exercises Options, Sells Shares Under 10b5-1 Plan

Analog Devices CEO Vincent Roche exercised options and sold 10,000 shares of common stock on September 2, 2025, under a pre-arranged 10b5-1 plan.

Summary

• Vincent Roche, Chair & CEO of Analog Devices Inc. (ADI), reported transactions on September 2, 2025.
• Roche exercised 10,000 Non-Qualified Stock Options at an exercise price of $94.41 per share.
• Concurrently, Roche sold 10,000 shares of common stock at a price of $246.5 per share.
• These transactions were executed pursuant to a Rule 10b5-1 trading plan adopted by Roche on May 23, 2025.
• Following these transactions, Roche directly beneficially owns 140,118.462 shares of common stock.
• Roche also indirectly beneficially owns 34,828 shares through the Vincent Roche 2023 Grantor Retained Annuity Trust and 23,515 shares through the Vincent Roche 2024 Grantor Retained Annuity Trust.
• Roche holds 94,637 Non-Qualified Stock Options, which are fully vested.

Sentiment

Score: 5

Explanation: The transaction represents a routine, pre-planned insider sale under a 10b5-1 plan, which is a common practice for executives managing their equity holdings. While it involves a sale of shares, the pre-scheduled nature mitigates any immediate negative sentiment typically associated with insider selling.

Positives

• The transactions were conducted under a Rule 10b5-1 plan, indicating a pre-scheduled and transparent approach to managing equity holdings, which aligns with good corporate governance practices.
• The CEO retains a significant beneficial ownership stake in Analog Devices, both directly and indirectly through trusts, demonstrating continued alignment with shareholder interests.

Negatives

• The sale of shares by a key executive, even if pre-planned, can sometimes be perceived negatively by the market, although the impact is typically mitigated by the 10b5-1 plan disclosure.

Related Party Transactions

• Shares are held indirectly by the Vincent Roche 2023 Grantor Retained Annuity Trust (34,828 shares) and the Vincent Roche 2024 Grantor Retained Annuity Trust (23,515 shares).

Stakeholder Impact

• Shareholders: The sale of 10,000 shares by the CEO represents a minor reduction in direct insider ownership, but the transaction was pre-planned, reducing concerns about market timing. The CEO retains significant direct and indirect holdings, maintaining alignment with shareholder interests.

Key Dates

Recommendation

This Form 4 filing details a routine, pre-planned insider transaction by the CEO, involving the exercise of stock options and subsequent sale of shares under a 10b5-1 plan. Such transactions are common for executive compensation and personal financial planning and do not typically signal a change in the company's fundamental outlook or warrant a change in investment recommendation based solely on this filing. The CEO retains substantial direct and indirect beneficial ownership.

Keywords

Analog Devices, ADI, Vincent Roche, Insider Trading, Form 4, Stock Option Exercise, Share Sale, 10b5-1 Plan, CEO, Semiconductors